Pure Global AI
Disease / condition

Diabetic Macular Edema clinical trials

Free access to 301 studies10+ countriesUpdated daily42 recruiting
VerifiedClinicalTrials.gov · WHO ICTRP · regional registries
301
Total trials
10+
Countries
10+
Sponsors
42
Recruiting
By phase
N/A88
Phase 260
Phase 346
Phase 446
Early Phase 130
By status
Completed166
Recruiting42
Unknown40
Not yet recruit...24
Withdrawn14
Top countries
United States of America80
China23
Brazil10
Iran10
Canada10
Top sponsors
Novartis Pharmaceu...13
Jaeb Center for He...11
Hoffmann-La Roche8
Shahid Beheshti Un...8
Allergan7
Recent trials
Latest clinical trials for Diabetic Macular Edema
Outcomes After Vitrectomy in Eyes With Tractional Diabetic Macular Edema
Rehab Azzam
NCT06316388Not yet recr...
Everads Injector in Suprachoroidal Administration of TA Suspension, for Treatment of Patients With DME
Everads Therapy · Israel
NCT06314217Recruiting
Efficacy and Safety of Conbercept for Diabetic Macular Edema Combined With Severe Non-proliferative Diabetic Retinopathy
Shanghai Eye Disease Preventio... · China
NCT06305143Recruiting
Phase
Phase 4
A Clinical Study Evaluating the Safety, Tolerability and Initial Efficacy of SKG0106 Intravitreal Injection in Diabetic Macular Edema (DME) Patients
Wang Min · China
NCT06237777Recruiting
Phase
Phase 1
Relationship Between Dyslipidemia and The Response of Diabetic Macular Edema to Intravitreal Injection of Anti Vascular Endothelial Growth Factor Agents
Sohag University · Egypt
NCT06205979Recruiting
Phase
Phase 1
Study of EYP-1901 in Patients With Diabetic Macular Edema (DME)
EyePoint Pharmaceuticals, Inc.
NCT06099184Not yet recr...
Phase
Phase 2
Observational Study of Adult Participants With Diabetic Macular Edema and Suboptimal Response to Anti-Vascular Endothelial Growth Factor Treated With Dexamethasone Intravitreal Implant
AbbVie
NCT05978622Not yet recr...
Describing Patient With DME, Their Patient Journey and Disease Progression
Boehringer Ingelheim
NCT05966753Not yet recr...
Post Marketing Study to Evaluate the Safety and Effectiveness of Brolucizumab in Patients With Diabetic Macular Edema.
Novartis Pharmaceuticals
NCT05959304Not yet recr...
Gene Therapy for Diabetic Macular Edema
Frontera Therapeutics · China
NCT05916391Recruiting
Phase
Phase 1
Efficacy and Safety of RC28-E Versus Aflibercept in Diabetic Macular Edema
RemeGen Co., Ltd.
NCT05885503Not yet recr...
Phase
Phase 3
A Study of ASKG712 in Patients With Diabetic Macular Edema
AskGene Pharma, Inc. · China
NCT05940428Not yet recr...
Phase
Phase 1
Comparative Study Between IVI of Ranibizumab With and Without Prior ACP in Patients With DME Using OCT-A
Ain Shams University · Egypt
NCT05861466Recruiting
Phase
Phase 4
Intravitreal Dexamethasone Implant for Refractory Diabetic Macular Edema:
Dar El Oyoun Hospital · Egypt
NCT05847088Completed
Ranibizumab 0.5 mg for Diabetic Macular Edema With Initial Intensive Treatment in the Real World Clinical Setting in Korea (Rising K)
Novartis Pharmaceuticals · South Korea
NCT05815212Completed
Short-term Effect of Intravitreal Dexamethasone Implant in Refractory Diabetic Macular Edema
Asociación para Evitar la Cegu... · Mexico
NCT05736081Completed
Phase
Phase 2/3
Evaluation of Tonabersat for DME
Jaeb Center for Health Researc...
NCT05727891Not yet recr...
Phase
Phase 2
IVI Aflibercept Before and After Phaco in DME.
Al Hadi Hospital · Kuwait
NCT05731089Completed
Study to Evaluate the Efficacy and Safety of RZ402 in Diabetic Macular Edema (DME)
Rezolute · United States of America
NCT05712720Recruiting
Phase
Phase 2
Suprachoroidal Sustained-Release OXU-001 Compared to Intravitreal Ozurdex® in the Treatment of Diabetic Macular Edema
Oxular Limited
NCT05697809Not yet recr...
Phase
Phase 2
About this profile

Access comprehensive clinical trial information for Diabetic Macular Edema through Pure Global AI's free database. This collection includes 301 clinical trials across multiple phases including N/A, Phase 2, Phase 3. Currently, 42 trials are actively recruiting participants.

Research for Diabetic Macular Edema is being conducted in United States of America, China, Brazil and 7+ other countries. Leading sponsors include Novartis Pharmaceuticals and Jaeb Center for Health Research. Pure Global AI offers free access to clinical trial data from ClinicalTrials.gov, WHO ICTRP, and regional registries worldwide.

Pure Global AI provides free access to 301 clinical trials studying Diabetic Macular Edema, aggregated from major global registries including ClinicalTrials.gov, WHO ICTRP, and regional databases.

The trials span multiple phases, from early Phase 1 safety studies to large-scale Phase 3 efficacy trials, conducted across 10+ countries.

Top research sponsors include Novartis Pharmaceuticals, Jaeb Center for Health Research, Hoffmann-La Roche, among others.